World News | China’s vaccines proven ineffective become world problem: report

Beijing [China], Dec 7 (ANI): In the early days of the Covid-19 outbreak, China discouraged the use of international vaccines Moderna and Pfizer and instead promoted its domestic product, Sincovac. According to the Singapore Post, a news outlet with an online portfolio, repeated outbreaks of the new coronavirus in China, coupled with a tested and proven lack of effectiveness of its vaccine, have caused problems for Chinese citizens and people around the world.

The Singapore Post reported, “Recent studies have shown that Chinese vaccines such as Kexing vaccine are only 61% effective on death and 55% effective on hospitalization, while Moderna and Pfizer have performed much better and are Both vaccines are as high as 90% protective.”

Read also | Arizona: Polygamist leader Samuel Bateman had 20 wives, many of them minors, the FBI said.

Also, according to the Singapore Post, while global manufacturers are focusing on producing vaccines, China is busy smearing and promoting the effectiveness of mRNA vaccines.

Traditional vaccines implant weakened or inactivated bacteria into our bodies, however, mRNA vaccines teach cells how to make a protein that triggers an immune response if someone becomes infected, the report said. Sincovac is producing weaker T-cell vaccines that fail to provide protection against the deadly virus, according to a study in The Lancet.

Read also | North Korea has publicly executed two teenagers for “heinous crimes” they committed watching South Korean films.

Studies like these have raised public concerns, leading to mass public rejection of Chinese vaccines, so that Chinese authorities are unable to vaccinate their vast population, and ultimately lead to an extreme zero-Covid policy.

According to the Singapore Post, countries such as Turkey, which received Sincovac Biotech’s Chinese vaccine CoronaVac, have not been popular with local populations due to distrust of Chinese research and cases of data tampering involving China just to sell its vaccine internationally. .

Indonesia issued a statement in December 2020 stating that the efficacy of the Chinese vaccine they received was 97%. Although they changed the statement in 2021 to say it was only 65% ​​effective. Similarly, according to the Singapore Post, Brazil declared the efficacy of Chinese products to be 78%, but this was later changed to 50.4%.

Thailand and Indonesia have also withdrawn their Chinese vaccines from the public and replaced them with AstraZeneca. Although, for its healthcare workers, the Moderna vaccination was arranged because they faced death even after being fully vaccinated with Sincovac. Malaysia also later announced that it too would soon replace its vaccine with the Pfizer one, the Singapore Post reported.

According to the report, all these attempts at data manipulation ultimately failed to conceal the inability of the Chinese vaccine to provide protection against the disease. But now that the vaccine has entered the international market, it has become an issue across China’s borders, worsening China’s already damaged global image, according to the Singapore Post. (Arnie)

(This is an unedited and auto-generated story from a Syndicated News feed, the content body may not have been modified or edited by LatestLY staff)